首页/数据集/SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

NIAID Data Ecosystem2026-05-01 收录

肾髓质癌转录调控

铁死亡抵抗

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE181001 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

应用场景：

创建时间：

2023-06-05

铁死亡抵抗

癌症分子特征

We have used in vivo selection to isolate GPX4 knockout 786-O cells that have evaded ferroptosis in vivo in mouse xenograft experiments. RNA-seq and Exome-seq profiling were performed to characterize

NIAID Data Ecosystem100

RNA-sequencing and Exome-sequencing analysis of ferroptosis-resistant 786-O GPX4-null carcinoma cells following in vivo selection

铁死亡抵抗

癌症基因组数据

We have used in vivo selection to isolate GPX4 knockout 786-O cells that have evaded ferroptosis in vivo in mouse xenograft experiments. RNA-seq and Exome-seq profiling were performed to characterize

NIAID Data Ecosystem70

Supporting data for "The Mevalonate Pathway: A Key Player in Protecting Hepatocellular Carcinoma from Ferroptosis"

肝癌研究

铁死亡抵抗

My studies explore the underlying mechanism of how the Mevalonate pathway supported liver cancer against ferroptosis via CoQ10 production and selenoprotein translation. We identified MVD as an NRF2 ta

DataCite Commons2024-08-26 更新20

De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defense

癌细胞代谢

铁死亡抵抗

De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defense

integrated proteome resources70

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. [RNAseq]. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. [RNAseq]

肾髓样癌分子机制

铁死亡抵抗

Renal medullary carcinoma (RMC) is an aggressive tumour driven by bi-allelic loss of SMARCB1 and tightly associated with sickle cell trait. However, the cell-of-origin and oncogenic mechanism remain p

NIAID Data Ecosystem20

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

资源简介：

相关数据集